Abbott Diabetes Care has recalled certain glucose monitoring sensors after reports of seven deaths and more than 700 injuries possibly linked to malfunctioning devices that could provide inaccurate ...

Certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus devices have been recalled Charlotte Phillipp is a Weekend Writer-Reporter at PEOPLE. She has been working at PEOPLE since 2024, and was previously ...

The U.S. Food and Drug Administration has issued an alert for “a potentially high-risk issue” regarding two glucose monitor sensors that have been malfunctioning and linked to multiple fatalities. The ...

Abbott Diabetes Care has alerted patients that the FreeStyle Libre 3 and Libre 3 Plus glucose sensors may provide incorrect low glucose readings. The FDA posted an Early Alert about the issue on ...

Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.

A medical device correction has been initiated for 3 million continuous glucose monitors. Certain Freestyle Libre 3 systems may provide incorrect low glucose readings, which can lead to serious health ...

Abbott Laboratories is moving to replace more than a million of its glucose monitors in circulation after receiving reports of more than 700 severe adverse events and seven deaths possibly linked to ...

Incorrect low glucose readings from some Abbott continuous glucose monitoring (CGM) sensors have been potentially linked to 736 severe adverse events and seven deaths globally. Abbott reported this ...

Abbott issued a medical device correction for some of its glucose sensors after internal testing found that some sensors may provide false low glucose readings. Hundreds of adverse events and seven ...

Nov 24 (Reuters) - Abbott Laboratories (ABT.N), opens new tab said on Monday it has begun a correction in the United States for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitoring ...